Discontinue Use of Ciprofloxacin for Invasive Meningococcal Disease Post-Exposure Prophylaxis

The Department of Health issued the attached Health Advisory on August 14, 2024 – Discontinue Use of Ciprofloxacin for Invasive Meningococcal Disease Post-Exposure Prophylaxis.

Due to increasing resistance, NYSDOH and NYCDOH are recommending that health care providers discontinue the use of ciprofloxacin as post-exposure prophylaxis for close contacts of patients with invasive meningococcal disease in New York. Prescribe rifampin or ceftriaxone as post-exposure prophylaxis instead.

DOH Contact: bcdc@health.ny.gov

NYSHFA | NYSCAL CONTACTS:

Lisa Volk, RN, B.P.S., LNHA
Executive Director, Foundation for Quality Care
518-462-4800 x15

Tarrah Quinlan, RN, BSN
Director of Education Program Development and Member Operations
518-462-4800 x20